ArticleBMC geriatrics2025
A nomogram to predict sarcopenia in older adults: a multi-center study in rural China.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSarcopenia is closely associated with activity limitations, falls and fractures, all serving as major causes of physiological deterioration and even mortality in older adults. The purpose of this study was to develop and validate a novel nomogram for predicting the risk of sarcopenia in Chinese older adults from rural areas.
methodsOverall, 611 older adults were enrolled from the Thyroid Diseases in Older Population (TOPS) study and randomly assigned to the training and validation datasets in a ratio of 8:2. Based on the risk factors for sarcopenia identified by stepwise multivariate logistic regression, a nomogram to predict sarcopenia in older adults was created. Its discrimination ability, calibration accuracy and clinical utility were assessed via the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA), respectively. Additionally, a web-based nomogram was developed.
resultsA nomogram to predict sarcopenia in older adults was created by incorporating the following variables: age (years), sex, body mass index (BMI, kg/m2), free triiodothyronine (FT3), total cholesterol (TC), triglyceride (TG), and TG/HDL-C. The area under the curve (AUC) of the nomogram was 0.813 (95% CI 0.775–0.846) in the training dataset and 0.819 (95% CI 0.739–0.883) in the validation dataset. Both calibration curves and DCA verified high calibration accuracy and clinical utility of the nomogram.
conclusionsA nomogram is created based on routine laboratory values of blood testing, showing an outstanding ability to predict sarcopenia in older adults from rural areas in China accurately, specifically and cost-effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.